Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Silberstein

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|February 22, 1985
Effects on Trichinella spiralis of host responses to purified antigensD S Silberstein, D D Despommier
Journal of Health Care Finance|November 3, 2011
Summary of prospective quantification of reimbursement recovery from inpatient acute care outliersGerald S Silberstein, Albert S Paulson
Current Pain and Headache Reports|March 17, 2001
How to pick optimal acute treatment for migraine headacheM Sanchez del Rio, S Silberstein
Immunology Today|October 8, 2014
The regulation of human eosinophil function by cytokinesD S Silberstein, J R David
The Journal of Biological Chemistry|November 25, 1992
The 48-kDa subunit of the mammalian oligosaccharyltransferase complex is homologous to the essential yeast protein WBP1S Silberstein, D J Kelleher, R Gilmore
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1990
Inhibition of IgG-triggered human eosinophil function by IL-4P Baskar, D S Silberstein, S H Pincus
The Journal of Parasitology|December 1, 1984
The site of ecdysis of the L1 larva of Trichinella spiralisV Capo, D D Despommier, D S Silberstein
Headache|June 10, 2000
Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research GroupS Silberstein, N Mathew, J Saper, et al.
Cephalalgia : an International Journal of Headache|March 23, 2007
Improved identification of allodynic migraine patients using a questionnaireA Ashkenazi, S Silberstein, M Jakubowski, et al.
The Journal of Experimental Medicine|November 1, 1991
Identification of C3 beta chain as the human serum eosinophil cytotoxicity inhibitorM S Minkoff, W W Wong, D S Silberstein
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|February 22, 1985
Effects on Trichinella spiralis of host responses to purified antigensD S Silberstein, D D Despommier
Journal of Health Care Finance|November 3, 2011
Summary of prospective quantification of reimbursement recovery from inpatient acute care outliersGerald S Silberstein, Albert S Paulson
Current Pain and Headache Reports|March 17, 2001
How to pick optimal acute treatment for migraine headacheM Sanchez del Rio, S Silberstein
Immunology Today|October 8, 2014
The regulation of human eosinophil function by cytokinesD S Silberstein, J R David
The Journal of Biological Chemistry|November 25, 1992
The 48-kDa subunit of the mammalian oligosaccharyltransferase complex is homologous to the essential yeast protein WBP1S Silberstein, D J Kelleher, R Gilmore
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1990
Inhibition of IgG-triggered human eosinophil function by IL-4P Baskar, D S Silberstein, S H Pincus
The Journal of Parasitology|December 1, 1984
The site of ecdysis of the L1 larva of Trichinella spiralisV Capo, D D Despommier, D S Silberstein
Headache|June 10, 2000
Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research GroupS Silberstein, N Mathew, J Saper, et al.
Cephalalgia : an International Journal of Headache|March 23, 2007
Improved identification of allodynic migraine patients using a questionnaireA Ashkenazi, S Silberstein, M Jakubowski, et al.
The Journal of Experimental Medicine|November 1, 1991
Identification of C3 beta chain as the human serum eosinophil cytotoxicity inhibitorM S Minkoff, W W Wong, D S Silberstein
Pageof 8